详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Shi, Yuankai[1] * ; Wu, Jianqiu[2] ; Wang, Zhen[3] ; Zhang, Liling[4] ; Wang, Zhao[5]

; Zhang, Mingzhi[6] ; Cen, Hong[7,8] ; Peng, Zhigang[9] ; Li, Yufu[10] ; Fan, Lei[11] ; Guo, Ye[12] ; Ma, Liping[13] ; Cui, Jie[14] ; Gao, Yuhuan[15] ; Yang, Haiyan[16] ; Zhang, Hongyu[17] ; Wang, Lin[18] ; Zhang, Weihua[19] ; Zhang, Huilai[20] ; Xie, Liping[21] ; Jiang, Ming[22] ; Zhou, Hui[23] ; Shuang, Yuerong[24] ; Su, Hang[25] ; Ke, Xiaoyan[26] ; Jin, Chuan[27] ; Du, Xin[28,29] ; Du, Xin[28,29] ; Liu, Li[30] ; Xi, Yaming[31] ; Ge, Zheng[32] ; Feng, Ru[33] ; Zhang, Yang[34] ; Zhou, Shengyu[35] ; Xie, Fan[36] ; Gao, Chao[36] ;

单位： [1]Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Canc Hosp, Natl Canc Ctr,Natl Clin Res Ctr Canc, Beijing, Peoples R China [2]Jiangsu Canc Hosp, Dept Oncol, Nanjing, Peoples R China [3]Linyi Canc Hosp, Dept Oncol, Linyi, Shandong, Peoples R China [4]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lymphoma, Wuhan, Peoples R China [5]Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing, Peoples R China [6]Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China [7]Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hematol Lymphoma & Pediat Oncol, Nanning, Peoples R China [8]Oncol Med Coll, Nanning, Peoples R China [9]Guangxi Med Univ, Dept Oncol, First Affiliated Hosp, Nanning, Peoples R China [10]Henan Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China [11]Jiangsu Prov Hosp, Dept Hematol, Nanjing, Peoples R China [12]Shanghai Oriental Hosp, Dept Oncol, Shanghai, Peoples R China [13]Sun Yat Sen Univ, Dept Hematol, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [14]Gansu Prov Canc Hosp, Dept Hematol, Lanzhou, Peoples R China [15]Hebei Med Univ, Dept Hematol, Hosp 14, Shijiazhuang, Hebei, Peoples R China [16]Zhejiang Canc Hosp, Dept Lymphoma, Hangzhou, Peoples R China [17]Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 5, Zhuhai, Peoples R China [18]Hainan Gen Hosp, Dept Oncol, Haikou, Hainan, Peoples R China [19]Shanxi Med Univ, Dept Hematol, Affiliated Hosp 1, Taiyuan, Peoples R China [20]Tianjin Med Univ Canc Inst & Hosp, Dept Lymphoma, Tianjin, Peoples R China [21]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China [22]Sichuan Univ, Dept Oncol, West China Hosp, Chengdu, Peoples R China [23]Hunan Canc Hosp, Dept Lymphoma, Changsha, Peoples R China [24]Jiangxi Canc Hosp, Dept Oncol, Nanchang, Jiangxi, Peoples R China [25]Gen Hosp Peoples Liberat Army China, Dept Lymphoma, Med Ctr 5, Beijing, Peoples R China [26]Peking Univ, Dept Hematol, Hosp 3, Beijing, Peoples R China [27]Guangzhou Med Univ, Dept Oncol, Canc Ctr, Guangzhou, Peoples R China [28]Guangdong Prov Peoples Hosp, Dept Hematol, Guangzhou, Peoples R China [29]Shenzhen Second Peoples Hosp, Dept Hematol, Shenzhen, Peoples R China [30]Fourth Mil Med Univ, Dept Hematol, Tangdu Hosp, Xian, Peoples R China [31]Lanzhou Univ, Dept Hematol, Hosp 1, Lanzhou, Peoples R China [32]Southeast Univ, Dept Hematol, Zhongda Hosp, Nanjing, Peoples R China [33]Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China [34]Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China [35]Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targe, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [36]Genor Biopharma Co Ltd, Dept Med Sci, Shanghai, Peoples R China

出处：

DOI：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 2 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2018]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Canc Hosp, Natl Canc Ctr,Natl Clin Res Ctr Canc, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial

文献详情